Evaluation of sialic acid concentrations and its association with the use of hormonal contraceptives

Evaluation of sialic acid concentrations and its association with the use of hormonal contraceptives

Andrea G. Rodríguez-López 1, Mónica L. Córdova-Serrano 2, Ana L. González-Bolaños 2, Karen B. Téllez-Blanco 2, Laura S. Marín-Jaureguí 3, Ma. José Santoyo-Treviño 4, Aida C. Hernández-Arteaga 4

1 Physical-Mathematical Department, Universidad Autónoma de San Luis Potosí, S.L.P., Mexico; 2 Faculty of Chemical Sciences, Universidad Autónoma de San Luis Potosí, S.L.P., Mexico; 3 Division of Molecular and Translational Medicine, Research Center of Health Science and Biomedicine, Universidad Autónoma de San Luis Potosí, S.L.P., Mexico; 4 Coordination for Innovation and Application of Science and Technology. Universidad Autónoma de San Luis Potosí, S.L.P., Mexico

Andrea G. Rodríguez-López, Mónica L. Córdova-Serrano, Ana L. González-Bolaños, Karen B. Téllez-Blanco, Laura S. Marín-Jaureguí, Ma. José Santoyo-Treviño, Aida C. Hernández-Arteaga

La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.

*Correspondencia: Aida C. Hernández-Arteaga, Email no disponible

Resumen

Objective: To evaluate the relationship between the use of HC and the concentration of Sialic acid (CSA) detected in the saliva of 120 women from San Luís Potosí, Mexico. Methods: Three groups were evaluated: control group, HC intake shorter than 4 years, and HC intake longer than 4 years. A questionnaire was applied, anthropometric measures were taken, and collection of saliva samples was carried out. The samples were analyzed with Raman-SERS, for which silver nanoparticles were synthesized, and the measurement of SA was held. Results: The concentrations were divided into three SA groups: normal (≤ 4 mg/dL), risk (> 4-7 mg/dL), and altered (> 7 mg/dL). The maximum CSA was detected, which was 9.2 mg/dL. All the volunteers who used the intrauterine system (IUS) and most of the ones who used the pills and subdermal implant (SI) presented risk and altered concentrations. Conclusions: That there is an association between the HC and the CSA, presenting a higher concentration, those volunteers who used IUS, contraceptive pills, and SI.

Palabras clave:  Breast cancer. Hormonal contraceptive. Sialic acid. SERS. Raman spectroscopy.

Contenido